Literature DB >> 6802867

Identification of immunoglobulin heavy-chain isotypes of specific antibodies of horse 46 group B meningococcal antiserum.

P Z Allen, M Glode, R Schneerson, J B Robbins.   

Abstract

Hyperimmune horse serum from a single animal (horse 46) immunized with group B (strain B-11) meningococcal vaccine provides a standardized, readily available diagnostic reagent used in primary isolation medium and for serogrouping of meningococci. Identification of the heavy-chain isotypes of specific anticapsular polysaccharide and anti-lipopolysaccharide isolated from horse 46 serum revealed a differential distribution in the occurrence of immunoglobulin classes. Meningococcal anticapsular antibodies of horse 46 serum were restricted predominately to the immunoglobulin M (IgM) class, with only trace amounts of IgGa present, whereas anti-lipopolysaccharide concomitantly produced showed a heterogeneity in its heavy-chain isotypes, consisting of IgM, IgGa, IgGb, moderate amounts of IgB, and a small amount of IgA.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6802867      PMCID: PMC272085          DOI: 10.1128/jcm.15.2.324-329.1982

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Structural determination of the sialic acid polysaccharide antigens of Neisseria meningitidis serogroups B and C with carbon 13 nuclear magnetic resonance.

Authors:  A K Bhattacharjee; H J Jennings; C P Kenny; A Martin; I C Smith
Journal:  J Biol Chem       Date:  1975-03-10       Impact factor: 5.157

2.  Immunochemical similarity between polysaccharide antigens of Escherichia coli 07: K1(L):NM and group B Neisseria meningitidis.

Authors:  D L Kasper; J L Winkelhake; W D Zollinger; B L Brandt; M S Artenstein
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

3.  Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis.

Authors:  J B Robbins; G H McCracken; E C Gotschlich; F Orskov; I Orskov; L A Hanson
Journal:  N Engl J Med       Date:  1974-05-30       Impact factor: 91.245

4.  Equine anti-hapten antibody. VII. Anti-lactoside antibody induced by a bacterial vaccine.

Authors:  Y D Kim; F Karush
Journal:  Immunochemistry       Date:  1973-06

5.  Antigenic relationship between Escherichia coli and Neisseria meningitidis.

Authors:  O Grados; W H Ewing
Journal:  J Infect Dis       Date:  1970 Jul-Aug       Impact factor: 5.226

6.  Studies on equine immunoglobulins. IV. Immunoglobulins of the donkey.

Authors:  P Z Allen; E J Dalton
Journal:  Immunology       Date:  1975-01       Impact factor: 7.397

7.  Equine anti-hapten antibody. IX. IgM anti-lactose antibodies.

Authors:  M M Chua; D O Morgan; F Karush
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

8.  Studies on the meningococcal polysaccharides. II. Composition and chemical properties of the group B and group C polysaccharide.

Authors:  T Y Liu; E C Gotschlich; F T Dunne; E K Jonssen
Journal:  J Biol Chem       Date:  1971-08-10       Impact factor: 5.157

9.  Studies on equine immunoglobulins. II. Anigenic interrelationships among horse IgG(T) and antipneumococcal gamma-1-component.

Authors:  C M Helms; P Z Allen
Journal:  J Immunol       Date:  1970-11       Impact factor: 5.422

10.  Equine antihapten antibody. The subunits and fragments of anti-beta-lactoside antibody.

Authors:  J H Rockey
Journal:  J Exp Med       Date:  1967-02-01       Impact factor: 14.307

View more
  7 in total

1.  Capsular polysaccharide vaccine for Group B Neisseria meningitidis, Escherichia coli K1, and Pasteurella haemolytica A2.

Authors:  John B Robbins; Rachel Schneerson; Guilin Xie; Lars Å Hanson; Lars Åke-Hanson; Mark A Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-24       Impact factor: 11.205

2.  Oxidation of D-lactate and L-lactate by Neisseria meningitidis: purification and cloning of meningococcal D-lactate dehydrogenase.

Authors:  A L Erwin; E C Gotschlich
Journal:  J Bacteriol       Date:  1993-10       Impact factor: 3.490

3.  High-throughput identification of chemical inhibitors of E. coli Group 2 capsule biogenesis as anti-virulence agents.

Authors:  Carlos C Goller; Patrick C Seed
Journal:  PLoS One       Date:  2010-07-19       Impact factor: 3.240

4.  Antibodies to poly[(2----8)-alpha-N-acetylneuraminic acid] and poly[(2----9)-alpha-N-acetylneuraminic acid] are elicited by immunization of mice with Escherichia coli K92 conjugates: potential vaccines for groups B and C meningococci and E. coli K1.

Authors:  S J Devi; J B Robbins; R Schneerson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

5.  Identity between polysaccharide antigens of Moraxella nonliquefaciens, group B Neisseria meningitidis, and Escherichia coli K1 (non-O acetylated).

Authors:  S J Devi; R Schneerson; W Egan; W F Vann; J B Robbins; J Shiloach
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

Review 6.  Current status of meningococcal group B vaccine candidates: capsular or noncapsular?

Authors:  J Diaz Romero; I M Outschoorn
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

7.  A human monoclonal macroglobulin with specificity for alpha(2----8)-linked poly-N-acetyl neuraminic acid, the capsular polysaccharide of group B meningococci and Escherichia coli K1, which crossreacts with polynucleotides and with denatured DNA.

Authors:  E A Kabat; K G Nickerson; J Liao; L Grossbard; E F Osserman; E Glickman; L Chess; J B Robbins; R Schneerson; Y H Yang
Journal:  J Exp Med       Date:  1986-08-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.